Select a medication above to begin.
Emrelis (telisotuzumab vedotin-tllv)
telisotuzumab vedotin
Adult Dosing .
Dosage forms: INJ
New FDA Approval: May 2025
- [content coming soon]
nonsquamous non-small cell lung CA, locally advanced or metastatic
- [content coming soon]
- Info: anti-c-Met IgG1 monoclonal antibody attached to MMAE, a microtubule-disrupting agent, via a protease cleavable linker (antibody-drug conjugate)
Peds Dosing .
- Dosage forms: --
New FDA Approval: May 2025
- [Peds dosing is not applicable for this drug]